Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange
Filed with ASX · · 2 pages · English
Recce Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Recce Pharmaceuticals
- Appendix 4D and Half Yearly Report
- Recce Applies for Dual Listing on Frankfurt Stock Exchange
- Fiona Stanley Hospital Phase I/II Clinical Trial Agreement
- Further Encouraging COVID Results at Doherty
- R&D Incentive Rebate Received
Later from Recce Pharmaceuticals
- S&P DJI Announces March 2021 Quarterly Rebalance
- Anti-Viral Patent Granted in EU for RECCE Anti-Infectives
- Positive Sinusitis Data Against Infection
- Positive Sinusitis Patient Update - Special Access Scheme
- RECCE 327 Registered for Topical Burns Study in Humans
Follow Recce Pharmaceuticals into a list and get an email when it puts out news.
Follow Recce Pharmaceuticals